SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

Share Price is delayed by 15 minutes
Get Live Data
600.00    -10.00 (-1.64%)
Bid:
598.00
Ask:
600.00
Spread: 2.00 (0.334%)
Market Cap: £726.05m
OXB Live PriceLast checked at - London Stock Exchange

Intraday Oxford Biomedica Share Chart

Oxford Biomedica News

SMALL-CAP WINNERS & LOSERS: Molten Ventures wins UK MoD supply contract
9 May 2024

SMALL-CAP WINNERS & LOSERS: Molten Ventures wins UK MoD supply contract

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Thursday.

LONDON BROKER RATINGS: NatWest target raised, other lenders backed
9 May 2024

LONDON BROKER RATINGS: NatWest target raised, other lenders backed

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

LONDON BROKER RATINGS: Jefferies cuts AJ Bell; Deutsche likes ConvaTec
3 May 2024

LONDON BROKER RATINGS: Jefferies cuts AJ Bell; Deutsche likes ConvaTec

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

LONDON MARKET CLOSE: FTSE 100 as investors look to Fed rate decision
29 Apr 2024

LONDON MARKET CLOSE: FTSE 100 as investors look to Fed rate decision

(Alliance News) - The FTSE 100 in London closed higher on Monday, outperforming its European counterparts, as investors eye this week's interest rate ...

SMALL-CAP WINNERS & LOSERS: Oxford BioMedica bullish; Petrofac slumps
29 Apr 2024

SMALL-CAP WINNERS & LOSERS: Oxford BioMedica bullish; Petrofac slumps

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Monday.

Oxford Biomedica confident as it moves away from vaccine era
29 Apr 2024

Oxford Biomedica confident as it moves away from vaccine era

(Sharecast News) - Cell and gene therapy contract development and manufacturing organisation (CDMO) Oxford Biomedica reported stability in its core bu...